Integrating artificial intelligence with smartphone-based imaging for cancer detection in vivo
- PMID: 39616900
- PMCID: PMC11789447
- DOI: 10.1016/j.bios.2024.116982
Integrating artificial intelligence with smartphone-based imaging for cancer detection in vivo
Abstract
Cancer is a major global health challenge, accounting for nearly one in six deaths worldwide. Early diagnosis significantly improves survival rates and patient outcomes, yet in resource-limited settings, the scarcity of medical resources often leads to late-stage diagnosis. Integrating artificial intelligence (AI) with smartphone-based imaging systems offers a promising solution by providing portable, cost-effective, and widely accessible tools for early cancer detection. This paper introduces advanced smartphone-based imaging systems that utilize various imaging modalities for in vivo detection of different cancer types and highlights the advancements of AI for in vivo cancer detection in smartphone-based imaging. However, these compact smartphone systems face challenges like low imaging quality and restricted computing power. The use of advanced AI algorithms to address the optical and computational limitations of smartphone-based imaging systems provides promising solutions. AI-based cancer detection also faces challenges. Transparency and reliability are critical factors in gaining the trust and acceptance of AI algorithms for clinical application, explainable and uncertainty-aware AI breaks the black box and will shape the future AI development in early cancer detection. The challenges and solutions for improving AI accuracy, transparency, and reliability are general issues in AI applications, the AI technologies, limitations, and potentials discussed in this paper are applicable to a wide range of biomedical imaging diagnostics beyond smartphones or cancer-specific applications. Smartphone-based multimodal imaging systems and deep learning algorithms for multimodal data analysis are also growing trends, as this approach can provide comprehensive information about the tissue being examined. Future opportunities and perspectives of AI-integrated smartphone imaging systems will be to make cutting-edge diagnostic tools more affordable and accessible, ultimately enabling early cancer detection for a broader population.
Keywords: Artificial intelligence; Cancer detection in vivo; Early cancer detection; Efficient AI; Explainable AI; Multimodal AI; Smartphone-based imaging; Uncertainty-aware AI.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Artificial intelligence-assisted smartphone-based sensing for bioanalytical applications: A review.Biosens Bioelectron. 2023 Jun 1;229:115233. doi: 10.1016/j.bios.2023.115233. Epub 2023 Mar 17. Biosens Bioelectron. 2023. PMID: 36965381 Review.
-
Artificial intelligence for breast cancer detection and its health technology assessment: A scoping review.Comput Biol Med. 2025 Jan;184:109391. doi: 10.1016/j.compbiomed.2024.109391. Epub 2024 Nov 22. Comput Biol Med. 2025. PMID: 39579663
-
Artificial intelligence in bacterial diagnostics and antimicrobial susceptibility testing: Current advances and future prospects.Biosens Bioelectron. 2025 Jul 15;280:117399. doi: 10.1016/j.bios.2025.117399. Epub 2025 Mar 19. Biosens Bioelectron. 2025. PMID: 40184880 Review.
-
Advances in exosome plasmonic sensing: Device integration strategies and AI-aided diagnosis.Biosens Bioelectron. 2024 Dec 15;266:116718. doi: 10.1016/j.bios.2024.116718. Epub 2024 Aug 30. Biosens Bioelectron. 2024. PMID: 39216205 Review.
-
Artificial intelligence (AI) in restorative dentistry: current trends and future prospects.BMC Oral Health. 2025 Apr 18;25(1):592. doi: 10.1186/s12903-025-05989-1. BMC Oral Health. 2025. PMID: 40251567 Free PMC article. Review.
Cited by
-
Global epidemiological trends in prostate cancer burden: a comprehensive analysis from Global Burden of Disease Study 2021.Transl Androl Urol. 2025 May 30;14(5):1238-1252. doi: 10.21037/tau-2025-103. Epub 2025 May 27. Transl Androl Urol. 2025. PMID: 40529034 Free PMC article.
-
Advances in Multifunctional Nanoagents and SERS-Based Multimodal Sensing for Biotoxin in Foods.Foods. 2025 Apr 17;14(8):1393. doi: 10.3390/foods14081393. Foods. 2025. PMID: 40282794 Free PMC article. Review.
References
-
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A, Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: A Cancer Journal for Clinicians 74(3) (2024) 229–263. - PubMed
-
- Bray F, Laversanne M, Weiderpass E, Soerjomataram I, The ever-increasing importance of cancer as a leading cause of premature death worldwide, Cancer 127(16) (2021) 3029–3030. - PubMed
-
- Danaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M, Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors, The Lancet 366(9499) (2005) 1784–1793. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical